654 related articles for article (PubMed ID: 35336900)
1. Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA.
Mazzitelli M; Trunfio M; Sasset L; Leoni D; Castelli E; Lo Menzo S; Gardin S; Putaggio C; Brundu M; Garzotto P; Cattelan AM
Viruses; 2022 Feb; 14(3):. PubMed ID: 35336900
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
[TBL] [Abstract][Full Text] [Related]
3. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
[TBL] [Abstract][Full Text] [Related]
4. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
[TBL] [Abstract][Full Text] [Related]
5. Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?
Augello M; Bono V; Rovito R; Tincati C; Marchetti G
Curr HIV/AIDS Rep; 2023 Apr; 20(2):51-75. PubMed ID: 36680700
[TBL] [Abstract][Full Text] [Related]
6. Descriptive account of 18 adults with known HIV infection hospitalised with SARS-CoV-2 infection.
Madge S; Barber TJ; Hunter A; Bhagani S; Lipman M; Burns F
Sex Transm Infect; 2021 Aug; 97(5):392-393. PubMed ID: 32879027
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study.
Inciarte A; Gonzalez-Cordon A; Rojas J; Torres B; de Lazzari E; de la Mora L; Martinez-Rebollar M; Laguno M; Callau P; Gonzalez-Navarro A; Leal L; Garcia F; Mallolas J; Mosquera M; Marcos MA; Ambrosioni J; Miro JM; Martinez E; Blanco JL;
AIDS; 2020 Oct; 34(12):1775-1780. PubMed ID: 32773471
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study.
D'Souza G; Springer G; Gustafson D; Kassaye S; Alcaide ML; Ramirez C; Sharma A; Palella FJ; Tien PC; Detels R; Kempf MC; Lahiri CD; Rinaldo CR; French AL; Margolick JB; Adimora AA
HIV Res Clin Pract; 2020 Oct; 21(5):130-139. PubMed ID: 33211636
[TBL] [Abstract][Full Text] [Related]
9. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV.
Hoffmann C; Casado JL; Härter G; Vizcarra P; Moreno A; Cattaneo D; Meraviglia P; Spinner CD; Schabaz F; Grunwald S; Gervasoni C
HIV Med; 2021 May; 22(5):372-378. PubMed ID: 33368966
[TBL] [Abstract][Full Text] [Related]
10. IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
Kaddu-Mulindwa D; Keuser L; Lesan V; Rissland J; Smola S; Werdecker V; Stilgenbauer S; Christofyllakis K; Thurner L; Bewarder M; Lohr B; Lutz J; Lohse S; Rieke A
HIV Med; 2022 May; 23(5):564-569. PubMed ID: 34811869
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
Hensley KS; Jongkees MJ; Geers D; GeurtsvanKessel CH; Mueller YM; Dalm VASH; Papageorgiou G; Steggink H; Gorska A; Bogers S; den Hollander JG; Bierman WFW; Gelinck LBS; Schippers EF; Ammerlaan HSM; van der Valk M; van Vonderen MGA; Delsing CE; Gisolf EH; Bruns AHW; Lauw FN; Berrevoets MAH; Sigaloff KCE; Soetekouw R; Branger J; de Mast Q; Lammers AJJ; Lowe SH; de Vries RD; Katsikis PD; Rijnders BJA; Brinkman K; Roukens AHE; Rokx C
PLoS Med; 2022 Oct; 19(10):e1003979. PubMed ID: 36301821
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Outcomes and Risk Factors Among People Living with HIV.
Spinelli MA; Jones BLH; Gandhi M
Curr HIV/AIDS Rep; 2022 Oct; 19(5):425-432. PubMed ID: 35930187
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological, Virological and Serological Features of Coronavirus Disease 2019 (COVID-19) Cases in People Living With Human Immunodeficiency Virus in Wuhan: A Population-based Cohort Study.
Huang J; Xie N; Hu X; Yan H; Ding J; Liu P; Ma H; Ruan L; Li G; He N; Wei S; Wang X
Clin Infect Dis; 2021 Oct; 73(7):e2086-e2094. PubMed ID: 32803216
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2.
Mondi A; Cimini E; Colavita F; Cicalini S; Pinnetti C; Matusali G; Casetti R; Maeurer M; Vergori A; Mazzotta V; Gagliardini R; De Zottis F; Schininà V; Girardi E; Puro V; Ippolito G; Vaia F; Capobianchi MR; Castilletti C; Agrati C; Antinori A
J Med Virol; 2021 Mar; 93(3):1796-1804. PubMed ID: 32975842
[TBL] [Abstract][Full Text] [Related]
15. The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital.
Mnguni AT; Schietekat D; Ebrahim N; Sonday N; Boliter N; Schrueder N; Gabriels S; Sigwadhi LN; Zemlin AE; Chapanduka ZC; Ngah V; Yalew A; Jalavu T; Abdullah I; Tamuzi JL; Tembo Y; Davies MA; English R; Nyasulu PS
BMC Infect Dis; 2023 Feb; 23(1):123. PubMed ID: 36855103
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Severity of SARS-CoV-2 Infection in HIV-Infected Individuals During the First Year of the Pandemic.
Rial-Crestelo D; Bisbal O; Font R; De Lagarde M; Pinto A; Arce-García O; Santacreu-Guerrero M; Bermejo-Plaza L; Rubio R; Pulido F
J Acquir Immune Defic Syndr; 2022 Apr; 89(5):511-518. PubMed ID: 34954717
[TBL] [Abstract][Full Text] [Related]
17. Driving force of COVID-19 among people living with HIV in Wuhan, China.
Guo W; Ming F; Dong Y; Zhang Q; Liu L; Gao M; Zhang X; Mo P; Feng Y; Tang W; Liang K
AIDS Care; 2022 Nov; 34(11):1364-1371. PubMed ID: 35319336
[TBL] [Abstract][Full Text] [Related]
18. SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid.
González Guembe M; Tisner Pensado Y; Tejerina Picado F; Diez C; Pérez Latorre L; Fanciulli C; Parras Vázquez F; López Bernaldo de Quirós JC; Berenguer J; Padilla Ortega B; Machado M; Valerio Minero M; Muñoz Garcia P; Bouza Santiago E; Galar A; Catalan P; Alonso R; Bellón JM; Aldámiz-Echevarría Lois T;
AIDS Res Hum Retroviruses; 2022 May; 38(5):394-398. PubMed ID: 34969259
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
Overton ET; Weir IR; Zanni MV; Fischinger S; MacArthur RD; Aberg JA; Fitch KV; Frank M; Albrecht H; Goodenough E; Rhame FS; Fichtenbaum CJ; Bloomfield GS; Malvestutto C; Supparatpinyo K; McCallum S; Douglas PS; Alter G; Ribaudo H; Grinspoon SK
J Acquir Immune Defic Syndr; 2022 Aug; 90(4):377-381. PubMed ID: 35413022
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort.
Berenguer J; Díez C; Martín-Vicente M; Micán R; Pérez-Elías MJ; García-Fraile LJ; Vidal F; Suárez-García I; Podzamczer D; Del Romero J; Pulido F; Iribarren JA; Gutiérrez F; Poveda E; Galera C; Izquierdo R; Asensi V; Portilla J; López JC; Arribas JR; Moreno S; González-García J; Resino S; Jarrín I
Clin Microbiol Infect; 2021 Nov; 27(11):1678-1684. PubMed ID: 34186209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
